IDO1 expression was also reported to correlate with PD-L1 expression, and co-expressed IDO1 and PD-L1 may be an important target for immunotherapy in lung squamous cell carcinoma (Takada et al., 2019). The gene discussed is IDO1; the disease is squamous cell lung carcinoma.